Pancreatic Cancer Research

ResearcherCarol Davila University of Medicine and PharmacyActive in the last 2 years

Daniel Vasile Balaban

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-3436-8041; OpenAlex author ID A5075703957. Sources: OpenAlex.

Their work

Papers
8 (first author 4, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
19
Papers, trials and grants by year

2021: 1 paper · 2022: 2 papers · 2023: none · 2024: none · 2025: 2 papers · 2026: 3 papers

Papers 8

  1. Distinct Inflammatory and Dissemination Signatures Defined by Macrophage Migration Inhibitory Factor (MIF), Interleukin-8 (IL-8/CXCL8), and Stem Cell Factor (S… First author DOI 10.3390/diagnostics16091373↗
  2. Pancreatic Steatosis and Survival Outcomes in Pancreatic Ductal Adenocarcinoma: A Systematic Review of the Current Evidence. Co-author DOI 10.3390/diagnostics16152476↗
  3. Clinical Significance of Cytokeratin 19-Fragments (CYFRA 21-1), Osteopontin (OPN) and Human Epididymis Protein 4 (HE4) in Pancreatic Adenocarcinoma. First author DOI 10.3390/ijms27031562↗
  4. Endoscopic Ultrasound-Guided Radiofrequency Ablation for Pancreatic Adenocarcinoma: A Scoping Review with Meta-Analysis. First author DOI 10.3390/diagnostics15040437↗
  5. Dysregulation of genes involved in the long-chain fatty acid transport in pancreatic ductal adenocarcinoma. Co-author DOI 10.4251/wjgo.v17.i1.98409↗
  6. Risk Factors for Pancreatic Cancer in Patients with New-Onset Diabetes: A Systematic Review and Meta-Analysis. First author DOI 10.3390/cancers14194684↗
  7. Clinical characteristics and outcomes in carbohydrate antigen 19-9 negative pancreatic cancer. Co-author DOI 10.5306/wjco.v13.i7.630↗
  8. Dysregulation of miRNAs Targeting the IGF-1R Pathway in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cells10081856↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mariana Jinga · 5 shared papers, 2022–2026 · strength 1.45
  2. Augustin Cătălin Dima · 2 shared papers, 2026 · strength 0.54
  3. Cătălin Cârstoiu · 2 shared papers, 2026 · strength 0.54
  4. Cătălina Vlăduţ · 3 shared papers, 2021–2025 · strength 0.53
  5. Vlad Herlea · 2 shared papers, 2021–2025 · strength 0.39
  6. Maria Dobre · 2 shared papers, 2021–2025 · strength 0.39
  7. Elena Milanesi · 2 shared papers, 2021–2025 · strength 0.39
  8. Daniela Tabacelia · 1 shared paper, 2025 · strength 0.27
  9. Cristian George Ţieranu · 1 shared paper, 2025 · strength 0.27
  10. Cristian Gheorghe · 1 shared paper, 2025 · strength 0.27
  11. Stephen P. Pereira · 1 shared paper, 2025 · strength 0.27
  12. Adrian Săftoiu · 1 shared paper, 2025 · strength 0.27
  13. Radu Cristian Poenaru · 1 shared paper, 2025 · strength 0.25
  14. Mihail Eugen Hinescu · 1 shared paper, 2025 · strength 0.25
  15. Claudia Mellenthin · 1 shared paper, 2022 · strength 0.22
  16. Ana Dugic · 1 shared paper, 2022 · strength 0.22
  17. Stéphane Cullati · 1 shared paper, 2022 · strength 0.22
  18. Săndica Bucurica · 1 shared paper, 2022 · strength 0.14
  19. Gabriel Constantinescu · 1 shared paper, 2021 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.